Important Regulatory Notification: Patient Safety Gaps Identified in Ipca Laboratories UK Ltd PILs

On September 30, 2025, Ipca Laboratories UK Ltd issued an urgent notification to the Medicines and…

Critical Updates on Medical Device Field Safety Notices Issued from 18 to 22 August 2025

Between 18 and 22 August 2025, several Field Safety Notices (FSNs) were issued for medical devices,…

Essential MHRA Updates: August 2025 Safety Guidance for Medicines and Medical Devices

The Medicines and Healthcare products Regulatory Agency (MHRA) has released its latest safety advice for August…

Medical Device Field Safety Notices: Updates from August 25–29, 2025

Field Safety Notices issued between August 25 and 29, 2025, provide crucial updates for stakeholders involved…

Profemur Modular Neck Hip Implants: Heightened Risk of Fractures and Revision Surgery Identified

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued an important update regarding the risks…

Regulatory Alert: Patient Information Leaflet Defect for Hikma Farmacêutica’s Gemcitabine 2g/52.6ml Infusion Concentrate

On September 30, 2025, Hikma Farmacêutica (Portugal) S.A issued a notification to the Medicines and Healthcare…

Critical Updates: Field Safety Notices Issued from 8–12 September 2025

Important updates for clinical, quality, and regulatory teams: A series of Field Safety Notices (FSNs) were…

Critical Updates: Field Safety Notices Issued for Medical Devices (15–19 September 2025)

Healthcare professionals and regulatory teams, please take note. Between 15 and 19 September 2025, a range…